{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:37:00Z","timestamp":1794465420593,"version":"4.9.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jaci.2021.12.768","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T18:08:17Z","timestamp":1640196497000},"page":"844-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field"],"prefix":"10.1016","volume":"149","author":[{"given":"Marc E.","family":"Rothenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna K.B.","family":"Hottinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Gonsalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn T.","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret H.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Talley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calies","family":"Menard-Katcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macie","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Genta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna","family":"Chehade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Spergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema S.","family":"Aceves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S.","family":"Dellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.12.768_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2019.11.007","article-title":"Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: multi-site study","volume":"145","author":"Shoda","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.12.768_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12016-019-08732-1","article-title":"Eosinophilic gastrointestinal disorders","volume":"57","author":"Gonsalves","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.12.768_bib3","doi-asserted-by":"crossref","first-page":"984","DOI":"10.14309\/ajg.0000000000000228","article-title":"Increasing rates of diagnosis, substantial co-occurrence, and variable treatment patterns of eosinophilic gastritis, gastroenteritis, and colitis based on 10-year data across a multicenter consortium","volume":"114","author":"Pesek","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2021.12.768_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/01.mpg.0000221903.61157.4e","article-title":"Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up","volume":"42","author":"Chehade","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2021.12.768_bib5","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.cgh.2017.05.050","article-title":"Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017","volume":"15","author":"Mansoor","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2021.12.768_bib6","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1016\/j.jaip.2021.06.026","article-title":"Comparison of nonesophageal eosinophilic gastrointestinal disorders with eosinophilic esophagitis: a nationwide survey","volume":"9","author":"Yamamoto","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.12.768_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MPG.0000000000002040","article-title":"Nonesophageal eosinophilic gastrointestinal disorders: clinical care and future directions","volume":"67","author":"Naramore","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2021.12.768_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(20)31911-9","article-title":"Su1001 Clinical characteristics and disease features from a multicenter longitudinal cohort of eosinophilic gastrointestinal disorders may inform future studies","volume":"158","author":"Gupta","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.12.768_bib9","unstructured":"Hirano I, ed. Prospective evaluation of a novel, endoscopic activity assessment system for eosinophilic gastritis. In: Digestive Disease Week; May 19, 2019; San Diego, Calif."},{"key":"10.1016\/j.jaci.2021.12.768_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/modpathol.2010.221","article-title":"Eosinophilic gastritis: histopathological characterization and quantification of the normal gastric eosinophil content","volume":"24","author":"Lwin","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaci.2021.12.768_bib11","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2014.07.026","article-title":"Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome","volume":"134","author":"Caldwell","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.12.768_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fmed.2017.00261","article-title":"Eosinophilic gastrointestinal disorders pathology","volume":"4","author":"Collins","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2021.12.768_bib13","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jaip.2020.12.054","article-title":"Diagnostic delay in patients with eosinophilic gastritis and\/or duodenitis: a population-based study","volume":"9","author":"Chehade","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.12.768_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(20)30790-3","article-title":"229 results from the ELEMENT study: prospective study of elemental diet in eosinophilic gastroenteritis nutrition trial","volume":"158","author":"Gonsalves","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.12.768_bib15","article-title":"Machine learning approach for biopsy-based identification of eosinophilic esophagitis reveals importance of global features","author":"Czyzewski","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jaci.2021.12.768_bib16","doi-asserted-by":"crossref","unstructured":"Dellon ES, Gonsalves N, Rothenberg ME, Hirano I, Chehade M, Peterson KA, et\u00a0al. Determination of biopsy yield that optimally detects eosinophilic gastritis and\/or duodenitis in a randomized trial of lirentelimab [published online ahead of print June 2, 2021]. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2021.05.053.","DOI":"10.1016\/j.cgh.2021.05.053"},{"key":"10.1016\/j.jaci.2021.12.768_bib17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cgh.2011.07.017","article-title":"Natural history of eosinophilic gastroenteritis","volume":"9","author":"Pineton de Chambrun","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2021.12.768_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2468-1253(18)30005-0","article-title":"Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus","volume":"3","author":"Walker","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2021.12.768_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.gtc.2014.02.015","article-title":"Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis","volume":"43","author":"Hirano","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaci.2021.12.768_bib20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s10620-018-4978-7","article-title":"Impact on health-related quality of life in adults with eosinophilic gastritis and gastroenteritis: a qualitative assessment","volume":"63","author":"Bedell","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2021.12.768_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaci.2019.11.012","article-title":"Consortium of Eosinophilic Gastrointestinal Disease Researchers. Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)","volume":"145","author":"Aceves","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.12.768_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.iac.2015.05.004","article-title":"Eosinophilia associated with disorders of immune deficiency or immune dysregulation","volume":"35","author":"Williams","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2021.12.768_bib23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jaci.2013.02.030","article-title":"High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders","volume":"132","author":"Abonia","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.12.768_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11894-018-0645-6","article-title":"Diagnosis, natural history and treatment of eosinophilic enteritis: a review","volume":"20","author":"Pineton de Chambrun","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jaci.2021.12.768_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2019.11.011","article-title":"Diagnosis and treatment of eosinophilic esophagitis","volume":"145","author":"Gonsalves","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.12.768_bib26","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1007\/s10620-019-05961-4","article-title":"Association between endoscopic and histologic findings in a multicenter retrospective cohort of patients with non-esophageal eosinophilic gastrointestinal disorders","volume":"65","author":"Pesek","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2021.12.768_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00383-020-04832-8","article-title":"Eosinophilic colitis in children: a new and elusive enemy?","volume":"37","author":"Raffaele","year":"2021","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jaci.2021.12.768_bib28","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.jaip.2019.03.020","article-title":"Overestimation of the diagnosis of eosinophilic colitis with reliance on billing codes","volume":"7","author":"Muir","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.12.768_bib29","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/ajg.2014.166","article-title":"Eosinophilic gastritis in children: clinicopathological correlation, disease course, and response to therapy","volume":"109","author":"Ko","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2021.12.768_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11938-002-0002-5","article-title":"Eosinophilic gastroenteritis","volume":"5","author":"Caldwell","year":"2002","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.jaci.2021.12.768_bib31","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0016-5085(95)90637-1","article-title":"Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula","volume":"109","author":"Kelly","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.12.768_bib32","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/apt.16396","article-title":"Letter: budesonide for functional dyspepsia with duodenal eosinophilia\u2014randomised, double-blind, placebo-controlled parallel-group trial","volume":"53","author":"Talley","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaci.2021.12.768_bib33","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","article-title":"Anti-siglec-8 antibody for eosinophilic gastritis and duodenitis","volume":"383","author":"Dellon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.12.768_bib34","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MPG.0000000000002817","article-title":"High patient disease burden in a cross-sectional, multicenter contact registry study of eosinophilic gastrointestinal diseases","volume":"71","author":"Jensen","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaci.2021.12.768_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","article-title":"Epidemiology and natural history of eosinophilic esophagitis","volume":"154","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.12.768_bib36","doi-asserted-by":"crossref","first-page":"S-110","DOI":"10.1016\/S0016-5085(21)01011-8","article-title":"Endoscopy and systematic biopsy of patients with chronic gastrointestinal symptoms leads to high discovery rate of patients who meet histologic criteria for eosinophilic gastritis and\/or eosinophilic duodenitis","volume":"160","author":"Talley","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.12.768_bib37","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1053\/j.gastro.2020.12.016","article-title":"Proton pump inhibitors reduce duodenal eosinophilia, mast cells, and permeability in patients with functional dyspepsia","volume":"160","author":"Wauters","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.12.768_bib38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.cgh.2007.05.015","article-title":"Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study","volume":"5","author":"Talley","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2021.12.768_bib39","first-page":"1","article-title":"Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring","volume":"30","author":"Collins","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaci.2021.12.768_bib40","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.cgh.2020.08.013","article-title":"Mast cell and eosinophil counts in gastric and duodenal biopsy specimens from patients with and without eosinophilic gastroenteritis","volume":"19","author":"Reed","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2021.12.768_bib41","article-title":"Ileocolonic histopathological and microbial alterations in the irritable bowel syndrome: a nested community case-control study","volume":"12","author":"Talley","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jaci.2021.12.768_bib42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2350\/11-05-0130.1","article-title":"Quantity and distribution of eosinophils in the gastrointestinal tract of children","volume":"9","author":"DeBrosse","year":"2006","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.jaci.2021.12.768_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2016.03.004","article-title":"Histologic analysis of eosinophils and mast cells of the gastrointestinal tract in healthy Canadian children","volume":"54","author":"Chernetsova","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaci.2021.12.768_bib44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00428-018-2405-2","article-title":"Eosinophils in the gastrointestinal tract: how much is normal?","volume":"473","author":"Silva","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jaci.2021.12.768_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/PAS.0000000000000760","article-title":"Primary colonic eosinophilia\u00a0and eosinophilic colitis in adults","volume":"41","author":"Turner","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2021.12.768_bib46","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ajg.2015.158","article-title":"Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia","volume":"110","author":"Cirillo","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2021.12.768_bib47","series-title":"BEST (Biomarkers E, and other Tools) resource","year":"2016"},{"key":"10.1016\/j.jaci.2021.12.768_bib48","unstructured":"Office USGP. Title 21\u2014Food and drugs; Chapter I\u2014Food and Drug Administration, Department of Health and Human Services (continued; Subchapter D\u2014Drugs for human use; Part 314\u2014 Applications for FDA approval to market a new drug; Subpart B\u2014Applications; Section 314.50\u2014Content and format of an application. 50 FR 7493, Feb. 22, 1985 April 1, 2011. In: Code of Federal Regulations (annual edition). Available at: https:\/\/www.govinfo.gov\/app\/details\/CFR-2011-title21-vol5\/CFR-2011-title21-vol5-sec314-50. Accessed July 21, 2021."},{"key":"10.1016\/j.jaci.2021.12.768_bib49","unstructured":"Office USGP. Title 21\u2014Food and drugs; Chapter I\u2014Food and Drug Administration, Department of Health and Human Services (continued); Subchapter D\u2014Drugs for human use; Part 314\u2014 Applications for FDA approval to market a new drug; Subpart D\u2014FDA action on applications and abbreviated applications; Section \u00a7 314.126\u2014Adequate and well-controlled studies. 50 FR 7493, Feb. 22, 1985, as amended at 50 FR 21238, May 23, 1985; 55 FR 11580, Mar. 29, 1990; 64 FR 402, Jan. 5, 1999; 67 FR 9586, Mar. 4, 2002 April 1, 2020. In: Code of Federal Regulations (annual edition). Available at: https:\/\/www.govinfo.gov\/app\/details\/CFR-2020-title21-vol5\/CFR-2020-title21-vol5-sec314-126. Accessed July 21, 2021."},{"key":"10.1016\/j.jaci.2021.12.768_bib50","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.dld.2014.11.009","article-title":"Clinical characteristics, treatment outcomes, and resource utilization in children and adults with eosinophilic gastroenteritis","volume":"47","author":"Reed","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaci.2021.12.768_bib51","doi-asserted-by":"crossref","unstructured":"Sarosiek I, Van Natta M, Parkman HP, Abell T, Koch KL, Kuo B, et\u00a0al. Effect of domperidone therapy on gastroparesis symptoms: results of a dynamic cohort study by NIDDK Gastroparesis Consortium [published online ahead of print June 2, 2021]. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2021.05.063.","DOI":"10.1016\/j.cgh.2021.05.063"},{"key":"10.1016\/j.jaci.2021.12.768_bib52","doi-asserted-by":"crossref","unstructured":"Reed CC, Ketchem CJ, Miller TL, Dellon ES. Psychiatric comorbidities are highly prevalent in nonesophageal eosinophilic gastrointestinal diseases [published online ahead of print May 28, 2021]. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2021.05.044.","DOI":"10.1016\/j.cgh.2021.05.044"},{"key":"10.1016\/j.jaci.2021.12.768_bib53","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.dld.2021.03.002","article-title":"Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: a narrative review","volume":"53","author":"Armuzzi","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jaci.2021.12.768_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170209","article-title":"Factors associated with health-related quality of life in Mexican lupus patients using the LupusQol","volume":"12","author":"Etchegaray-Morales","year":"2017","journal-title":"PLoS One"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921026713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921026713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:35:55Z","timestamp":1758792955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921026713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0091674921026713"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.12.768","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.12.768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}